期刊文献+

IL-10对尾加压素Ⅱ诱导的大鼠血管平滑肌细胞增殖的影响 被引量:4

Effects of interleukin-10 on the proliferation of vascular smooth muscle cells induced by urotensin Ⅱ
下载PDF
导出
摘要 目的 :探讨白细胞介素 10 (interleukin 10 ,IL 10 )对血管活性肽尾加压素Ⅱ (urotensinⅡ ,UⅡ )诱导的大鼠血管平滑肌细胞 (vascularsmoothmusclecell,VSMC)增殖的影响及其作用机制。方法 :在培养的大鼠主动脉VSMC上 ,采用3H 胸腺嘧啶 (3H TdR)参入测定VSMCDNA合成速率 ,Westernblot及免疫沉淀法测定粘着斑激酶(focaladhensionkinase ,FAK)的表达及活性。结果 :IL 10 (10 -10 ~ 10 -8g·ml-1)呈浓度依赖的方式抑制UⅡ (10 -8mol·L-1)诱导的VSMC3H TdR参入增加 (P <0 .0 5或P <0 .0 1)和FAK的活性上调 (P <0 .0 5 ) ,但各组间FAK的蛋白表达差异无显著性。结论 :IL 10可能通过抑制FAK活性的上调 。 Objective: Exploring the effect of interleukin 10 (IL 10) on the changes of urotensin Ⅱ (UⅡ) induced rat vascular smooth muscle cell (VSMC) proliferation and focal adhesion kinase (FAK) signal. Methods: On cultured VSMC of rat, 3H TdR incorporation was used to evaluate the speed of DNA synthesis, Western blot and immunoprecipitation were applied to assay the expression and activity of FAK. Results: IL 10(10 -8 -10 -10 g·ml -1 )inhibited the increasing of 3H TdR incorporation and FAK activity, which was induced by UⅡ( P <0.05 or P <0.01). But there was no difference of the expression of FAK among the groups. Conclusion: IL 10 can inhibit the VSMC proliferation by downloading the activity of FAK, which stimulated by UⅡ.
出处 《北京大学学报(医学版)》 CAS CSCD 北大核心 2001年第4期332-334,共3页 Journal of Peking University:Health Sciences
基金 国家自然科学基金 (39730 2 2 0 )资助&&
关键词 白细胞介素10 药理学 尿紧张素类 血管平滑肌细胞增殖 Interleukin 10/pharmacol Urotensins/pharmacol Muscle, smooth, vascular/drug eff
  • 相关文献

参考文献2

  • 1奥斯伯F 金斯顿RE.精编分子生物学实验指南[M].北京:科学出版社,1998.29-108.
  • 2奥斯伯 F,精编分子生物学实验指南,1998年,366页

共引文献114

同被引文献47

  • 1李田昌,庞永政,苏静怡,唐朝枢.丝裂素活化蛋白激酶活性测定[J].基础医学与临床,1996,16(2):78-80. 被引量:64
  • 2Matsushita M, Shichiri M, Fukai N, et al. Urotensin II is an autocrine/paracrine growth factor for the porcine renal epithelial cell line. Endocrinol 2003 ; 144 (5) : 1825-1831.
  • 3Maguire JJ, Kue RE, Davenport AP. Ophen-receptor ligand human urotensin II: receptor localization in human tissues and comparison of vasoconstrictor responses with endothelin-1. Br J Pharmacol 2000; 131 (3) :441-446.
  • 4Watanabe T, Pakala R, Katagiri T, et al. Synergistic effect of urotensin-II with mildly oxidized LDL on DNA synthesis on vascular smooth muscle ceils. Circulation 2001 ;4( 1 ) :16-18.
  • 5Matsushita M, Shichiri M, Fukai N, et al. Urotensin II is an autocrine/paracrine growth factor for the porcine renal epithelial cell line. Endocrinology 2003 ; 144 ( 5 ) : 1825-1831.
  • 6Maguire JJ, Kue RE, Davenport AP. Ophen-receptor ligand human urotensin II : receptor localization in human tissues and comparison of vasoconstrictor responses with endothelin-1. Br J Pharmacol 2000; 131 (3) :441-446.
  • 7[1]Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s [J]. Nature, 1991, 362: 801-809
  • 8[2]Ross R. Atherosclerosis is an inflammatory disease [J]. Am Heart J, 1999, 138(5 Pt 2): S419-20
  • 9[3]Biasucci LM, Liuzzo G, Buffon A, et al. The variable role of inflammation in acute coronary syndromes and in restenosis [J]. Semin Interv Cardiol, 1999, 4(3): 105-110
  • 10[4]Irfan L, Kailash B, Razzaque A. Interleukin-10: biology, role in inflammation and autoimmunity [J]. Ann Allergy Asthma Immunol, 1997, 79: 469-484

引证文献4

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部